Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs XPO Inc. Common Stock (XPO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs XPO Inc. Common Stock — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.65 (market cap $2.27B), while XPO Inc. Common Stock trades at $180.88 (market cap $21.30B). The key difference: XPO Inc. Common Stock is far larger — about 9.4× SELLAS Life Sciences Group Inc. Common Stock's market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, XPO Inc. Common Stock nearer its low. Which is the better fit depends on your goals.
| SLS | XPO | |
|---|---|---|
Market Cap | $2.27B | $21.30B |
Volume | 4,179,659 | 897,705 |
Sector | Health | Industrials |
52-Week High | $15.46 | $228.37 |
52-Week Low | $1.39 | $123.66 |
Enterprise Value | $2.14B | $24.99B |
Typical Hold Time | — | 0 Days |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About XPO Inc. Common Stock
XPO provides freight transportation services in North America and Europe. Its operations include less-than-truckload freight transportation and brokerage services supported by a technology platform.
Read more on XPO →
